Biomolecules & Therapeutics.2013;21(4):290-298.
This study examined the effects of calcium (Ca) gluconate on collagen-induced DBA mouse rheumatoid arthritis (CIA). A single daily dose of 200, 100 or 50 mg/kg Ca gluconate was administered orally to male DBA/1J mice for 40 days after initial collagen immunization. To ascertain the effects administering the collagen booster, CIA-related features (including body weight, poly-arthritis, knee and paw thickness, and paw weight increase) were measured from histopathological changes in the spleen, left popliteal lymph node, third digit and the knee joint regions. CIA-related bone and cartilage damage improved significantly in the Ca gluconate- administered CIA mice. Additionally, myeloperoxidase (MPO) levels in the paw were reduced in Ca gluconate-treated CIA mice compared to CIA control groups. The level of malondialdehyde (MDA), an indicator of oxidative stress, decreased in a dose-dependent manner in the Ca gluconate group. Finally, the production of IL-6 and TNF-alpha, involved in rheumatoid arthritis pathogenesis, were suppressed by treatment with Ca gluconate. Taken together, these results suggest that Ca gluconate is a promising candidate anti-rheumatoid arthritis agent, exerting anti-inflammatory, anti-oxidative and immunomodulatory effects in CIA mice.
Animals
;
Arthritis
;
Arthritis, Rheumatoid*
;
Body Weight
;
Calcium Gluconate*
;
Calcium*
;
Cartilage
;
Collagen
;
Humans
;
Immunization
;
Immunomodulation
;
Interleukin-6
;
Knee
;
Knee Joint
;
Lymph Nodes
;
Male
;
Malondialdehyde
;
Mice*
;
Mice, Inbred DBA
;
Oxidative Stress
;
Peroxidase
;
Spleen
;
Tumor Necrosis Factor-alpha
;
Water*